In an article 1 titled “Reprograming the tumor immunologic microenvironment using neoadjuvant chemotherapy in osteosarcoma” by Chuangzhong Deng, Yanyang Xu, Jianchang Fu, Xiaojun Zhu, Hongmin Chen, Huaiyuan Xu, Gaoyuan Wang, Yijiang Song, Guohui Song, Jinchang Lu, Ranyi Liu, Qinglian Tang, Wenlin Huang, Jin Wang, the funding information and acknowledgment sections are to be revised.
The revised funding information is stated as below:
National Natural Science Foundation of China, Grant/Award Number: 81702665, 81872183 and 81872268; Fundamental Research Funds for the Central Universities, Grant/Award Number: 19ykpy189; Science and Technology Program of Guangzhou, China, Grant/Award Number: 201710010165.
The revised acknowledgment is stated as below:
We thank Dr Xinke Zhang and Dr Linzhi Kong (Department of Pathology, SYSUCC) for IHC scoring. The raw data of this study were uploaded into the Research Data Deposit public platform (www.ressearchdata.org.cn). The RDD number for this dataset is RDDB2019000732. This study was supported by the National Natural Science Foundation of China (81872268, 81702665 and 81872183), the Fundamental Research Funds for the Central Universities (19ykpy189) and the Science and Technology Program of Guangzhou, China (201710010165).
The authors apologize for the error.
REFERENCE
- 1. Deng C, Xu Y, Fu J, et al. Reprograming the tumor immunologic microenvironment using neoadjuvant chemotherapy in osteosarcoma. Cancer Sci. 2020;111:1899‐1909. [DOI] [PMC free article] [PubMed] [Google Scholar]